美国风湿病学会关于COVID-19大流行期间成人风湿病管理的指南(第一版)
美国风湿病学会召集风湿病与感染病专家工作组,采用改良Delphi流程制定COVID-19大流行期间成人风湿病管理指南。初拟77条声明(36条中度共识、41条高度共识),合并为25条最终推荐。指南定位为「活文件」,将随证据更新。
要点
- 指南由风湿病与感染病专家工作组基于改良Delphi流程制定。
- 初拟77条声明合并为25条最终推荐,共识度为中至高度。
- 因证据水平低且文献快速变化,指南定位为「活文件」。
核心结论
- 工作组批准了25条最终推荐,旨在COVID-19大流行期间促进成人风湿病的最佳诊疗。
- 鉴于现有证据水平低且文献快速演变,该指南作为「活文件」发布,预计未来会更新。
研究设计与样本
- 工作组由来自北美的10名风湿病学家和4名感染病专家组成。
- 采用改良Delphi流程:2轮异步匿名邮件投票和3次全体小组网络研讨会。
- 专家以1-9分对草案声明进行同意度评分,中位值7-9、4-6、1-3分别定义为同意、不确定、不同意。
- 共识度根据投票离散程度分为低、中、高;批准需中位评分达到预设同意水平且共识度为中或高。
主要发现
- 初拟77条指南声明,其中36条为中度共识,41条为高度共识。
- 这些声明经合并后形成25条最终指南声明。
临床怎么用
- 本指南供风湿病诊疗提供者在COVID-19大流行期间管理成人风湿病患者时参考使用。
局限性
- 现有证据水平低且文献快速演变,指南需未来更新。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To provide guidance to rheumatology providers on the management of adult rheumatic disease in the context of the coronavirus disease 2019 (COVID-19) pandemic. METHODS: A task force, including 10 rheumatologists and 4 infectious disease specialists from North America, was convened. Clinical questions were collated, and an evidence report was rapidly generated and disseminated. Questions and drafted statements were reviewed and assessed using a modified Delphi process. This included 2 rounds of asynchronous anonymous voting by e-mail and 3 webinars with the entire panel. Task force members voted on agreement with draft statements using a 1-9-point numerical scoring system, and consensus was determined to be low, moderate, or high based on the dispersion of votes. For approval, median votes were required to meet predefined levels of agreement (median values of 7-9, 4-6, and 1-3 defined as agreement, uncertainty, or disagreement, respectively) with either moderate or high levels of consensus. RESULTS: The task force approved 77 initial guidance statements: 36 with moderate and 41 with high consensus. These were combined, resulting in 25 final guidance statements. CONCLUSION: These guidance statements are provided to promote optimal care during the current pandemic. However, given the low level of available evidence and the rapidly evolving literature, this guidance is presented as a "living document," and future updates are anticipated.
引用
- Mikuls TR, Johnson SR, Fraenkel L, et al. American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1. Arthritis Rheumatol. 2020. PMID: 32349183. doi:10.1002/art.41301
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。